Article Versions Notes

Krasowska D, Wróblewska-Łuczka P, Chojnacki M, Załuska-Ogryzek K, Kurzepa J, Łuszczki JJ. Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin—In Vitro Isobolographic Studies. Cancers. 2025; 17(15):2563. https://doi.org/10.3390/cancers17152563

Krasowska, Danuta, Paula Wróblewska-Łuczka, Michał Chojnacki, Katarzyna Załuska-Ogryzek, Jacek Kurzepa, and Jarogniew J. Łuszczki. 2025. "Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin—In Vitro Isobolographic Studies" Cancers 17, no. 15: 2563. https://doi.org/10.3390/cancers17152563

Krasowska, D., Wróblewska-Łuczka, P., Chojnacki, M., Załuska-Ogryzek, K., Kurzepa, J., & Łuszczki, J. J. (2025). Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin—In Vitro Isobolographic Studies. Cancers, 17(15), 2563. https://doi.org/10.3390/cancers17152563